FIELD: chemistry.
SUBSTANCE: invention relates to a method for producing an oligopeptide linker intermediate by the formulas (1)-(3), wherein each of AA1, AA2, AA3, and AA4 is independently selected from a group consisting of the following: -valine- (-Val-), -citrulline- (-Cit-), -alanine- (-Ala-), -lysine- (-Lys-), -phenylalanine- (-Phe-), -glycine- (-Gly-), -leucine- (-Leu-), and -isoleucine- (-Ile-). The method includes: 1) conducting a condensation reaction between the carbonylation reagent, 2-(trimethylsilyl)ethanol, and amino acid AA1, then amino acid AA2, or consecutively amino acid AA1, amino acid AA2, and amino acid AA3, or consecutively amino acid AA1, amino acid AA2, amino acid AA3, and amino acid AA4, resulting in a 2-(trimethylsilyl)ethoxycarbonyl-oligopeptide condensation product; 2) interacting the resulting 2-(trimethylsilyl)ethoxycarbonyl-oligopeptide condensation product and para-aminobenzyl alcohol resulting in a condensation product constituting 2-(trimethylsilyl)ethoxycarbonyl-oligopeptide-para-aminobenzyl alcohol. The carbonylation reagent has a structure of the formula (5), wherein each of R1 and R2 is independently selected from the group of values specified under formula (5). The proposed method is performed in mild reaction conditions and ensures production of a highly pure product. Invention also relates to an application of the above method for producing an antibody-drug conjugate.
EFFECT: creation of an intermediate applicable in producing an antibody-drug conjugate.
(1),
(2),
(3),
wherein R1 and R2 are independently selected from a group consisting of:
,.
10 cl, 4 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIBODY-DRUG CONJUGATE LOADED WITH BINARY TOXINS AND ITS USE | 2021 |
|
RU2795148C2 |
NEUROMEDIN AND SOMATOSTATIN RECEPTOR AGONISTS | 2000 |
|
RU2263680C2 |
PEPTIDE DRUGS WITH HIGH EFFECTIVENESS AGAINST INSULIN RESISTANCE | 2012 |
|
RU2602801C2 |
NOVEL COMPOUND WITH EFFECTS OF THROMBOLYSIS, ACCEPTING FREE RADICALS AND DIRECTED ACTION ON THROMBUS, AS WELL AS METHOD FOR PRODUCTION AND USE THEREOF | 2013 |
|
RU2604193C2 |
ANTIBODY-DRUG CONJUGATES BASED ON ERIBULIN AND APPLICATION METHODS | 2017 |
|
RU2754369C2 |
ANTI-MESOTHELIN ANTIBODY AND CONJUGATE THEREOF WITH MEDICINAL PRODUCTS | 2019 |
|
RU2747995C1 |
UROTENSIN-II AGONISTS AND ANTAGONISTS | 2001 |
|
RU2263679C2 |
LINKER FOR ANTIBODY-DRUG CONJUGATES AND THEIR USE | 2019 |
|
RU2792201C2 |
ANTI-CLAUDIN 18.2 ANTIBODY AND ITS ANTIBODY-DRUG CONJUGATE | 2022 |
|
RU2814164C2 |
TRI-, TETRA-, PENTA- AND POLYPEPTIDES AND THEIR THERAPEUTIC USE AS ANTIDEPRESSANT AGENT | 1995 |
|
RU2182910C2 |
Authors
Dates
2022-07-12—Published
2019-10-23—Filed